ClinicalTrials.Veeva

Menu

Smart-CKD/BP Study

A

Affiliated Hospital of Qinghai University

Status

Unknown

Conditions

CKD

Treatments

Behavioral: WeChat

Study type

Interventional

Funder types

Other

Identifiers

NCT03501745
20180330

Details and patient eligibility

About

Through remote management and propaganda of intelligent mobile phone, the standard rate of blood pressure control and the change of renal function were observed.

Enrollment

2 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. diagnosis in line with the 2012 international kidney disease: improving global outcomes (kidney disease improving global out-comes, KDIGO) of chronic kidney disease diagnosis standard of hypertension diagnosis, "China Hypertension Prevention Guide 2010" diagnostic criteria;
  2. and will have the use of intelligent mobile phone, and a network connection;
  3. at the age of 18-70.

Exclusion criteria

  1. GFR<15 ml/min or start replacement therapy;
  2. do not understand Chinese, do not understand Chinese;
  3. malignant tumor patients;
  4. have mental illness;
  5. there is consciousness disorder.

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

2 participants in 2 patient groups

Management Group
Other group
Treatment:
Behavioral: WeChat
control group
Other group
Treatment:
Behavioral: WeChat

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems